ArticleTheranostics2021

Erratum: CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum.

Wenzhi Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.